{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T16:32:41Z","timestamp":1791131561482,"version":"4.1.0"},"reference-count":185,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.arcmed.2007.10.001","type":"journal-article","created":{"date-parts":[[2007,12,4]],"date-time":"2007-12-04T10:31:22Z","timestamp":1196764282000},"page":"1-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":279,"title":["Neuroinflammation: Implications for the Pathogenesis and Molecular Diagnosis of Alzheimer's Disease"],"prefix":"10.1016","volume":"39","author":[{"given":"Leonel E.","family":"Rojo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge A.","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea A.","family":"Maccioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M.","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo B.","family":"Maccioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2007.10.001_bib1","first-page":"275","article-title":"Astrocytic nitric oxide triggers tau hyperphosphorylation in hippocampal neurons","volume":"18","author":"Saez","year":"2004","journal-title":"In Vivo"},{"key":"10.1016\/j.arcmed.2007.10.001_bib2","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1002\/jnr.20996","article-title":"Production of nerve growth factor by beta-amyloid-stimulated astrocytes induces p75NTR-dependent tau hyperphosphorylation in cultured hippocampal neurons","volume":"84","author":"Saez","year":"2006","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.arcmed.2007.10.001_bib3","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1146\/annurev.bi.59.070190.004031","article-title":"Cytokines: coordinators of immune and inflammatory responses","volume":"59","author":"Arai","year":"1990","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.arcmed.2007.10.001_bib4","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1179\/016164105X49463","article-title":"Tumor necrosis factor alpha, interleukin-1 beta, interleukin-6 and major histocompatibility complex molecules in the normal brain and after peripheral immune challenge","volume":"27","author":"Tonelli","year":"2005","journal-title":"Neurol Res"},{"key":"10.1016\/j.arcmed.2007.10.001_bib5","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0169-328X(92)90202-M","article-title":"Expression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells: modulation by interleukin-1","volume":"16","author":"Forloni","year":"1992","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.arcmed.2007.10.001_bib6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.yexcr.2004.01.002","article-title":"Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5\/p35 pathway","volume":"295","author":"Quintanilla","year":"2004","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.arcmed.2007.10.001_bib7","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.bbamcr.2006.10.010","article-title":"Neuroprotective effect of TNF\u03b1 against the \u03b2-amyloid neurotoxicity mediated by CDK5 kinase","volume":"1773","author":"Orellana","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.arcmed.2007.10.001_bib8","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0304-3940(95)11384-9","article-title":"Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and beta-amyloid production in cultures","volume":"188","author":"Del Bo","year":"1995","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.arcmed.2007.10.001_bib9","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1006\/nbdi.2000.0321","article-title":"Costimulatory effects of interferon-gamma and interleukin-1beta or tumor necrosis factor alpha on the synthesis of Abeta1-40 and Abeta1-42 by human astrocytes","volume":"7","author":"Blasko","year":"2000","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.arcmed.2007.10.001_bib10","doi-asserted-by":"crossref","first-page":"10738","DOI":"10.1073\/pnas.92.23.10738","article-title":"Amyloid beta peptide potentiates cytokine secretion by interleukin-1 beta-activated human astrocytoma cells","volume":"92","author":"Gitter","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.arcmed.2007.10.001_bib11","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1016\/S0024-3205(97)00936-3","article-title":"Effect of a carboxy-terminal fragment of the Alzheimer's amyloid precursor protein on expression of proinflammatory cytokines in rat glial cells","volume":"61","author":"Chong","year":"1997","journal-title":"Life Sci"},{"key":"10.1016\/j.arcmed.2007.10.001_bib12","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0736-5748(00)00012-5","article-title":"Induction of cytokines in glial cells surrounding cortical beta-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology","volume":"18","author":"Mehlhorn","year":"2000","journal-title":"Int J Dev Neurosci"},{"key":"10.1016\/j.arcmed.2007.10.001_bib13","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1001\/archneur.57.8.1153","article-title":"Cytokine gene expression as a function of the clinical progression of Alzheimer's disease dementia","volume":"57","author":"Luterman","year":"2000","journal-title":"Arch Neurol"},{"key":"10.1016\/j.arcmed.2007.10.001_bib14","article-title":"Blood inflammatory markers and risk of dementia: the study of brain aging","author":"Ravaglia","year":"2006","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.arcmed.2007.10.001_bib15","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000026329","article-title":"Transgenic models to study the actions of cytokines in the central nervous system","volume":"5","author":"Campbell","year":"1998","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.arcmed.2007.10.001_bib16","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1073\/pnas.94.4.1500","article-title":"Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain","volume":"94","author":"Heyser","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.arcmed.2007.10.001_bib17","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0188-4409(01)00316-2","article-title":"The molecular bases of Alzheimer's disease and other neurodegenerative disorders","volume":"32","author":"Maccioni","year":"2001","journal-title":"Arch Med Res"},{"key":"10.1016\/j.arcmed.2007.10.001_bib18","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1046\/j.1432-1327.2001.02024.x","article-title":"The protein kinase Cdk5. Structural aspects, roles in neurogenesis and involvement in Alzheimer's pathology","volume":"268","author":"Maccioni","year":"2001","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.arcmed.2007.10.001_bib19","doi-asserted-by":"crossref","first-page":"9020","DOI":"10.1073\/pnas.87.22.9020","article-title":"Nerve growth factor potentiates the neurotoxicity of beta amyloid","volume":"87","author":"Yankner","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.arcmed.2007.10.001_bib20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ng0195-21","article-title":"The Alzheimer's A beta peptide induces neurodegeneration and apoptotic cell death in transgenic mice","volume":"9","author":"LaFerla","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.arcmed.2007.10.001_bib21","doi-asserted-by":"crossref","first-page":"7533","DOI":"10.1523\/JNEUROSCI.16-23-07533.1996","article-title":"Amyloid beta peptide of Alzheimer's disease downregulates Bcl-2 and upregulates bax expression in human neurons","volume":"16","author":"Paradis","year":"1996","journal-title":"J Neurosci"},{"key":"10.1016\/j.arcmed.2007.10.001_bib22","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1111\/j.1471-4159.2006.04015.x","article-title":"Toxicity mediated by\u00a0soluble oligomers of beta-amyloid (1\u201342) on cholinergic SN56.B5.G4 cells","volume":"98","author":"Heinitz","year":"2006","journal-title":"J Neurochem"},{"key":"10.1016\/j.arcmed.2007.10.001_bib23","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0014-5793(99)01279-X","article-title":"Inhibition of tau phosphorylating protein kinase cdk5 prevents beta-amyloid-induced neuronal death","volume":"459","author":"Alvarez","year":"1999","journal-title":"FEBS Lett"},{"key":"10.1016\/j.arcmed.2007.10.001_bib24","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1006\/excr.2001.5152","article-title":"A Cdk5-p35 stable complex is involved in the beta-amyloid-induced deregulation of Cdk5 activity in hippocampal neurons","volume":"264","author":"Alvarez","year":"2001","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.arcmed.2007.10.001_bib25","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/1533317506289277","article-title":"Toxic advanced glycation end products (TAGE) theory in Alzheimer's disease","volume":"21","author":"Sato","year":"2006","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"10.1016\/j.arcmed.2007.10.001_bib26","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1242\/jcs.03323","article-title":"Abeta1\u201342 stimulates actin polymerization in hippocampal neurons through Rac1 and Cdc42 Rho GTP-ases","volume":"120","author":"Mendoza-Naranjo","year":"2007","journal-title":"J Cell Sci"},{"key":"10.1016\/j.arcmed.2007.10.001_bib27","first-page":"455","article-title":"Cerebrospinal fluid interleukin-1 beta (IL-1 beta) in Alzheimer's disease and neurological disorders","volume":"13","author":"Cacabelos","year":"1991","journal-title":"Methods Find Exp Clin Pharmacol"},{"issue":"202","key":"10.1016\/j.arcmed.2007.10.001_bib28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0304-3940(95)12192-7","article-title":"Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients","volume":"29","author":"Blum-Degen","year":"1995","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.arcmed.2007.10.001_bib29","doi-asserted-by":"crossref","first-page":"7611","DOI":"10.1073\/pnas.86.19.7611","article-title":"Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease","volume":"86","author":"Griffin","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.arcmed.2007.10.001_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s004010050664","article-title":"Neuritic plaque evolution in Alzheimer's disease is accompanied by transition of activated microglia from primed to enlarged to phagocytic forms","volume":"94","author":"Sheng","year":"1997","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.arcmed.2007.10.001_bib31","doi-asserted-by":"crossref","first-page":"11173","DOI":"10.1073\/pnas.93.20.11173","article-title":"Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death","volume":"93","author":"Ohshima","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.arcmed.2007.10.001_bib32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0896-6273(01)80044-1","article-title":"Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality","volume":"18","author":"Chae","year":"1997","journal-title":"Neuron"},{"key":"10.1016\/j.arcmed.2007.10.001_bib33","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1097\/00001756-200007140-00030","article-title":"Synaptic localization of p39, a neuronal activator of cdk5","volume":"11","author":"Humbert","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.arcmed.2007.10.001_bib34","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/45159","article-title":"Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration","volume":"402","author":"Patrick","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.arcmed.2007.10.001_bib35","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/371419a0","article-title":"p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5","volume":"371","author":"Tsai","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.arcmed.2007.10.001_bib36","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/(SICI)1097-4547(19991115)58:4<593::AID-JNR12>3.0.CO;2-4","article-title":"Interleukin-1 beta activates expression of cyclooxygenase-2 and inducible nitric oxide synthase in primary hippocampal neuronal culture: platelet-activating factor as a preferential mediator of cyclooxygenase-2 expression","volume":"58","author":"Serou","year":"1999","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.arcmed.2007.10.001_bib37","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/14660820050515089","article-title":"Expression of nitric oxide synthase isoforms in spinal cord in amyotrophic lateral sclerosis","volume":"1","author":"Phul","year":"2000","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"10.1016\/j.arcmed.2007.10.001_bib38","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1046\/j.1460-9568.1998.00168.x","article-title":"Microglial NO induces delayed neuronal death following acute injury in the striatum","volume":"10","author":"Takeuchi","year":"1998","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.arcmed.2007.10.001_bib39","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0301-0082(97)00021-X","article-title":"Interleukin-6 (IL-6)\u2014a molecule with both beneficial and destructive potentials","volume":"52","author":"Gadient","year":"1997","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.arcmed.2007.10.001_bib40","doi-asserted-by":"crossref","first-page":"7918","DOI":"10.1074\/jbc.275.11.7918","volume":"275","author":"Akama","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.arcmed.2007.10.001_bib41","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/0167-5699(91)90148-M","article-title":"IL-6-mediated events in Alzheimer's disease pathology","volume":"12","author":"Bauer","year":"1991","journal-title":"Immunol Today"},{"key":"10.1016\/j.arcmed.2007.10.001_bib42","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0014-5793(91)80460-K","article-title":"Alpha 2-macroglobulin synthesis in interleukin-6-stimulated human neuronal (SH-SY5Y neuroblastoma) cells. Potential significance for the processing of Alzheimer beta-amyloid precursor protein","volume":"282","author":"Ganter","year":"1991","journal-title":"FEBS Lett"},{"key":"10.1016\/j.arcmed.2007.10.001_bib43","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1096\/fj.99-1003rev","article-title":"The soluble interleukin 6 receptor: mechanisms of production and implications in disease","volume":"15","author":"Jones","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.arcmed.2007.10.001_bib44","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1146\/annurev.med.51.1.245","article-title":"Age-associated increased interleukin-6 gene expression, late-life diseases and frailty","volume":"51","author":"Ershler","year":"2000","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.arcmed.2007.10.001_bib45","doi-asserted-by":"crossref","first-page":"10709","DOI":"10.1523\/JNEUROSCI.3376-06.2006","article-title":"Interleukin-6 facilitates lipopolysaccharide-induced disruption in working memory and expression of other proinflammatory cytokines in hippocampal neuronal cell layers","volume":"26","author":"Sparkman","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.arcmed.2007.10.001_bib46","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/neu.10197","article-title":"MAPK signal transduction pathway mediates agrin effects on neurite elongation in cultured hippocampal neurons","volume":"55","author":"Karasewski","year":"2003","journal-title":"J Neurobiol"},{"key":"10.1016\/j.arcmed.2007.10.001_bib47","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3233\/JAD-2002-4508","article-title":"A\u03b2PP induces cdk5-dependent tau hyperphosphorylation in transgenic mice Tg2576","volume":"4","author":"Otth","year":"2000","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.arcmed.2007.10.001_bib48","first-page":"295","article-title":"Impact of in vivo administration of interleukin 3 on proliferation, differentiation, and chemosensitivity of acute myeloid leukemia","volume":"1","author":"Gore","year":"1995","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.arcmed.2007.10.001_bib49","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.febslet.2007.01.083","article-title":"Redundant promoter elements mediate IL-3-induced expression of a novel cytokine-inducible gene, cyclon","volume":"581","author":"Hoshino","year":"2007","journal-title":"FEBS Lett"},{"key":"10.1016\/j.arcmed.2007.10.001_bib50","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1126\/science.275.5300.661","article-title":"Regulation of neuronal survival by the serine threonine protein kinase Akt","volume":"275","author":"Dudek","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.arcmed.2007.10.001_bib51","unstructured":"Zambrano A. Participation of Interleukin-3 as a Neuroprotection Factor in Alzheimer's Disease. PhD thesis, Southern University of Chile, Valdivia; 2004."},{"key":"10.1016\/j.arcmed.2007.10.001_bib52","first-page":"283","article-title":"Bcl10 expression, rearrangement and mutation in MALT lymphoma: correlation with expression of nuclear factor-kappaB","volume":"19","author":"Ohshima","year":"2000","journal-title":"Int J Oncol"},{"key":"10.1016\/j.arcmed.2007.10.001_bib53","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/35088074","article-title":"Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signaling cascades","volume":"412","author":"Digicaylioglu","year":"2000","journal-title":"Nature"},{"issue":"Pt 4","key":"10.1016\/j.arcmed.2007.10.001_bib54","first-page":"693","article-title":"Toxicity of CSF in motor neurone disease: a potential route to neuroprotection","volume":"125","author":"Haw","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.arcmed.2007.10.001_bib55","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1182\/blood.V73.1.137.137","article-title":"In situ hybridization histochemistry localization of interleukin-3 mRNA in mouse brain","volume":"73","author":"Farrar","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.arcmed.2007.10.001_bib56","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1749-6632.1998.tb09554.x","article-title":"Interleukin-3 and interleukin-3 receptors in the brain","volume":"840","author":"Tabira","year":"1998","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.arcmed.2007.10.001_bib57","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0304-3940(94)90814-1","article-title":"Production of interleukin-3 by murine central nervous system neurons","volume":"182","author":"Konishi","year":"1994","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.arcmed.2007.10.001_bib58","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0736-5748(94)00059-C","article-title":"Enhanced survival and differentiation in vitro of different neuronal populations by some interleukins","volume":"13","author":"Moroni","year":"1995","journal-title":"Int J Dev Neurosci"},{"key":"10.1016\/j.arcmed.2007.10.001_bib59","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0006-8993(90)91775-C","article-title":"Trophic effect of granulocyte-macrophage colony-stimulating factor on central cholinergic neurons in vitro","volume":"532","author":"Kamegai","year":"1990","journal-title":"Brain Res"},{"key":"10.1016\/j.arcmed.2007.10.001_bib60","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1084\/jem.188.4.635","article-title":"Interleukin 3 prevents delayed neuronal death in the hippocampal CA1 field","volume":"188","author":"Wen","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.arcmed.2007.10.001_bib61","doi-asserted-by":"crossref","first-page":"11784","DOI":"10.1073\/pnas.0604681103","article-title":"Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1","volume":"103","author":"Butovsky","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.arcmed.2007.10.001_bib62","first-page":"113","article-title":"The role of TNF related apoptosis-inducing ligand in neurodegenerative diseases","volume":"2","author":"Huang","year":"2005","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.arcmed.2007.10.001_bib63","doi-asserted-by":"crossref","first-page":"7377","DOI":"10.1074\/jbc.M409071200","article-title":"Oxidation of cholesterol by amyloid precursor protein and beta-amyloid peptide","volume":"280","author":"Nelson","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.arcmed.2007.10.001_bib64","doi-asserted-by":"crossref","first-page":"21362","DOI":"10.1074\/jbc.M600504200","article-title":"Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner","volume":"281","author":"Takeuchi","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.arcmed.2007.10.001_bib65","doi-asserted-by":"crossref","first-page":"23658","DOI":"10.1074\/jbc.M513646200","article-title":"MAPK-activated protein kinase 2 deficiency in microglia inhibits proinflammatory mediator release and resultant neurotoxicity. Relevance to neuroinflammation in a transgenic mouse model of Alzheimer disease","volume":"281","author":"Culbert","year":"2006","journal-title":"J Biol Chem"},{"issue":"24","key":"10.1016\/j.arcmed.2007.10.001_bib66","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1523\/JNEUROSCI.4580-03.2004","article-title":"Tumor necrosis factor death receptor signaling cascade is required for amyloid-beta protein-induced neuron death","volume":"18","author":"Li","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.arcmed.2007.10.001_bib67","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.neurobiolaging.2006.02.012","article-title":"Serum TNF-\u03b1 levels are increased and correlate negatively with free IGF-I in Alzheimer disease","volume":"28","author":"Alvarez","year":"2007","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.arcmed.2007.10.001_bib68","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0531-5565(01)00191-7","article-title":"Proinflammatory cytokines in sera of elderly patients with dementia: levels in vascular injury are higher than those of mild-moderate Alzheimer's disease patients","volume":"37","author":"Paganelli","year":"2002","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.arcmed.2007.10.001_bib69","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/BF02815005","article-title":"Blood levels of histamine, IL-1 beta, and TNF-alpha in patients with mild to moderate Alzheimer disease","volume":"29","author":"Alvarez","year":"1996","journal-title":"Mol Chem Neuropathol"},{"key":"10.1016\/j.arcmed.2007.10.001_bib70","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1001\/archneur.63.8.1165","article-title":"Tumor necrosis factor alpha and interleukin 10 promoter region polymorphisms and risk of late-onset Alzheimer disease","volume":"63","author":"Ramos","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.arcmed.2007.10.001_bib71","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF03033983","article-title":"Role of the JAKs\/STATs pathway in the intracellular calcium changes induced by interleukin-6 in hippocampal neurons","volume":"8","author":"Orellana","year":"2005","journal-title":"Neurotoxicity Res"},{"key":"10.1016\/j.arcmed.2007.10.001_bib72","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/sj.cdd.4401143","article-title":"Neutralization of TRAIL death pathway protects human neuronal cell line from beta-amyloid toxicity","volume":"10","author":"Cantarella","year":"2003","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.arcmed.2007.10.001_bib73","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/00001756-200403220-00002","article-title":"TRAIL is expressed in the brain cells of Alzheimer's disease patients","volume":"15","author":"Uberti","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.arcmed.2007.10.001_bib74","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/87945","article-title":"TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice","volume":"7","author":"Wyss-Coray","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.arcmed.2007.10.001_bib75","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ajmg.b.30218","article-title":"Association studies of transforming growth factor-beta 1 and Alzheimer's disease","volume":"139","author":"Dickson","year":"2005","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.arcmed.2007.10.001_bib76","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1212\/WNL.59.3.371","article-title":"Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging","volume":"59","author":"Weaver","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.arcmed.2007.10.001_bib77","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.mad.2006.01.015","article-title":"Tumor necrosis factor-\u03b1 \u2212308A\/G polymorphism is associated with age at onset of Alzheimer's disease","volume":"127","author":"Lio","year":"2006","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.arcmed.2007.10.001_bib78","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0197-4580(03)00011-3","article-title":"Interleukin-1B polymorphism is associated with age at onset of Alzheimer's disease","volume":"24","author":"Sciacca","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.arcmed.2007.10.001_bib79","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1212\/01.WNL.0000158281.08946.68","article-title":"Serum inflammatory proteins and cognitive decline in older persons","volume":"64","author":"Dik","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.arcmed.2007.10.001_bib80","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1203\/01.PDR.0000163523.49021.53","article-title":"Variation in the interleukin-6 gene is associated with impaired cognitive development in children born prematurely: a preliminary study","volume":"58","author":"Harding","year":"2005","journal-title":"Pediatr Res"},{"key":"10.1016\/j.arcmed.2007.10.001_bib81","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.bbr.2003.12.018","article-title":"Cognitive function in young and adult IL (interleukin)-6 deficient mice","volume":"153","author":"Braida","year":"2004","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.arcmed.2007.10.001_bib82","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1212\/WNL.56.11.1595","article-title":"Rate of cognitive decline in AD is accelerated by the interleukin-1 alpha \u2212889 \u22171 allele","volume":"56","author":"Murphy","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.arcmed.2007.10.001_bib83","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s00455-001-0071-y","article-title":"Dementia with oropharyngeal dysphagia and myopathy","volume":"16","author":"Jerrard-Dunne","year":"2001","journal-title":"Dysphagi"},{"key":"10.1016\/j.arcmed.2007.10.001_bib84","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1210\/jc.2006-1268","article-title":"Peroxisome proliferator-activated receptor-\u03b3 (PPAR\u03b3) and adipose tissue\u2014understanding obesity-related changes in regulation of lipid and glucose metabolism","volume":"92","author":"Sharma","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2007.10.001_bib85","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/978-0-585-37970-8_8","article-title":"Effects of cytokines on cerebral neurotransmission. Comparison with the effects of stress","volume":"461","author":"Dunn","year":"1999","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.arcmed.2007.10.001_bib86","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1749-6632.2000.tb05368.x","article-title":"The mechanism of action of cytokines to control the release of hypothalamic and pituitary hormones in infection","volume":"917","author":"McCann","year":"2000","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.arcmed.2007.10.001_bib87","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0889-1591(02)00004-1","article-title":"Low levels of circulating inflammatory cytokines\u2212do they affect human brain functions?","volume":"16","author":"Pollmacher","year":"2002","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.arcmed.2007.10.001_bib88","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/ana.10733","article-title":"CCR1 is an early and specific marker of Alzheimer's disease","volume":"54","author":"Halks-Miller","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.arcmed.2007.10.001_bib89","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3109\/13550289909029743","article-title":"Chemokines\/chemokine receptors in the central nervous system and Alzheimer's disease","volume":"5","author":"Xia","year":"1999","journal-title":"J Neurovirol"},{"key":"10.1016\/j.arcmed.2007.10.001_bib90","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.neurobiolaging.2005.10.007","article-title":"Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer's disease","volume":"27","author":"Galimberti","year":"2006","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.arcmed.2007.10.001_bib91","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1046\/j.1471-4159.2001.00439.x","article-title":"Interleukin-1\u03b2 up-regulates expression of neurofilament light in human neuronal cells","volume":"78","author":"Rempel","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/j.arcmed.2007.10.001_bib92","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.brainres.2005.10.079","article-title":"Low molecular weight thiol amides attenuate MAPK activity and protect primary neurons from Abeta (1\u201342) toxicity","volume":"1069","author":"Bartov","year":"2006","journal-title":"Brain Res"},{"key":"10.1016\/j.arcmed.2007.10.001_bib93","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1111\/j.1471-4159.2005.02986.x","article-title":"Specific induction of macrophage inflammatory protein 1-alpha in glial cells of Sandhoff disease model mice associated with accumulation of N-acetylhexosaminyl glycoconjugates","volume":"92","author":"Tsuji","year":"2005","journal-title":"J Neurochem"},{"key":"10.1016\/j.arcmed.2007.10.001_bib94","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1016\/j.febslet.2006.04.064","article-title":"PTEN, a negative regulator of PI3 kinase signalling, alters tau phosphorylation in cells by mechanisms independent of GSK-3","volume":"580","author":"Kerr","year":"2006","journal-title":"FEBS Lett"},{"key":"10.1016\/j.arcmed.2007.10.001_bib95","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1001\/archneur.63.4.538","article-title":"Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease","volume":"63","author":"Galimberti","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.arcmed.2007.10.001_bib96","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.exger.2004.05.001","article-title":"Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism and risk of Alzheimer's disease in Italians","volume":"39","author":"Pola","year":"2004","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.arcmed.2007.10.001_bib97","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.neulet.2004.05.058","article-title":"The chemokine receptor CCR5-32 gene mutation is not protective against Alzheimer's disease","volume":"366","author":"Combarros","year":"2004","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.arcmed.2007.10.001_bib98","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.neurobiolaging.2003.11.008","article-title":"MCP-1 in Alzheimer's disease patients: A-2518G polymorphism and serum levels","volume":"25","author":"Fenoglio","year":"2004","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.arcmed.2007.10.001_bib99","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.neulet.2004.01.035","article-title":"No evidence for association of the monocyte chemoattractant protein-1(2518) gene polymorphism and Alzheimer disease","volume":"360","author":"Combarros","year":"2004","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.arcmed.2007.10.001_bib100","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.neulet.2004.12.056","article-title":"Association study of the chemokine, CXC motif, ligand 1 (CXCL1) gene with sporadic Alzheimer's disease in a Japanese population","volume":"379","author":"Tamura","year":"2005","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.arcmed.2007.10.001_bib101","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1007\/s00125-006-0281-9","article-title":"Association of soluble CD40 ligand with carotid atherosclerosis in Japanese type 1 diabetic patients","volume":"49","author":"Katakami","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.arcmed.2007.10.001_bib102","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1749-6632.2000.tb05424.x","article-title":"Variability of interactions between neuroendocrine and immunological functions in physiological aging and dementia of the Alzheimer's type","volume":"917","author":"Ferrari","year":"2000","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.arcmed.2007.10.001_bib103","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1126\/science.286.5448.2352","article-title":"Microglial activation resulting from CD40-CD40L interaction after beta-amyloid stimulation","volume":"286","author":"Tan","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.arcmed.2007.10.001_bib104","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1073\/pnas.98.4.1751","article-title":"Regulation of CD40 function by its isoforms generated through alternative splicing","volume":"98","author":"Tone","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.arcmed.2007.10.001_bib105","first-page":"163","article-title":"CD40\/CD40L dyad in the inflammatory and immune responses in the central nervous system","volume":"3","author":"Chen","year":"2006","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.arcmed.2007.10.001_bib106","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.neurobiolaging.2006.03.013","article-title":"NSAIDs and Alzheimer disease: epidemiological, animal model and clinical studies","volume":"28","author":"McGeer","year":"2006","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.arcmed.2007.10.001_bib107","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0165-0173(95)00011-9","article-title":"The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases","volume":"21","author":"McGeer","year":"1995","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.arcmed.2007.10.001_bib108","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0531-5565(02)00018-9","article-title":"Decrease of TGF-beta1 plasma levels and increase of nitric oxide synthase activity in leukocytes as potential biomarkers of Alzheimer's disease","volume":"37","author":"De Servi","year":"2002","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.arcmed.2007.10.001_bib109","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1440-1789.2006.00701.x","article-title":"Interleukin-18 and transforming growth factor-beta 1 plasma levels in Alzheimer's disease and vascular dementia","volume":"26","author":"Malaguarnera","year":"2006","journal-title":"Neuropathology"},{"key":"10.1016\/j.arcmed.2007.10.001_bib110","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1212\/WNL.47.2.425","article-title":"Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies","volume":"47","author":"McGeer","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.arcmed.2007.10.001_bib111","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/bmj.327.7407.128","article-title":"Effect of non-steroidal antiinflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies","volume":"327","author":"Etminan","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.arcmed.2007.10.001_bib112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/14656566.7.1.1","article-title":"Pharmacological strategies for the prevention of Alzheimer's disease","volume":"7","author":"Doraiswamy","year":"2006","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.arcmed.2007.10.001_bib113","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2174\/1567205054367883","article-title":"Non-steroidal anti-inflammatory drugs (NSAIDs) and other anti-inflammatory agents in the treatment of neurodegenerative disease","volume":"2","author":"Klegeris","year":"2005","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.arcmed.2007.10.001_bib114","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1212\/WNL.48.3.626","article-title":"Risk of Alzheimer's disease and duration of NSAID use","volume":"48","author":"Stewart","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.arcmed.2007.10.001_bib115","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1056\/NEJMoa010178","article-title":"Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease","volume":"345","author":"In't Veld","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcmed.2007.10.001_bib116","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1212\/WNL.59.6.880","article-title":"Reduced incidence of AD with NSAID but not H2 receptor antagonists: the Cache County study","volume":"59","author":"Zandi","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.arcmed.2007.10.001_bib117","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1212\/WNL.43.8.1609","article-title":"Clinical trial of indomethacin in Alzheimer's disease","volume":"43","author":"Rogers","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.arcmed.2007.10.001_bib118","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1212\/WNL.58.7.1050","article-title":"Randomized pilot study of nimesulide treatment in Alzheimer's disease","volume":"58","author":"Aisen","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.arcmed.2007.10.001_bib119","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1212\/WNL.53.1.197","article-title":"A double-blind, placebo-controlled trial of diclofenac\/misoprostol in Alzheimer's disease","volume":"53","author":"Scharf","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.arcmed.2007.10.001_bib120","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1001\/jama.289.21.2819","article-title":"Effects of rofecoxib or naproxen vs. placebo on Alzheimer disease progression: a randomized controlled trial","volume":"289","author":"Aisen","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.arcmed.2007.10.001_bib121","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0140-6736(01)05623-9","article-title":"Effect of hydroxychloroquine on progression of dementia in early Alzheimer's disease: an 18 month randomised, double-blind, placebo-controlled study","volume":"358","author":"Van Gool","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.arcmed.2007.10.001_bib122","first-page":"22","article-title":"Innate immunity in Alzheimer's disease: a model for local inflammatory reactions","volume":"1","author":"McGeer","year":"2001","journal-title":"Mol Interv"},{"key":"10.1016\/j.arcmed.2007.10.001_bib123","unstructured":"Sainati SM, Ingram DM, Talwalker S, Geis GS. Results of a double blind, placebo-controlled study of celecoxib for the progresi\u00f3n of Alzheimer's disease. In: Proceedings of the Sixth International Stockholm-Springfield Symposium of Advances in Alzheimer Therapy;2000. p. 180."},{"key":"10.1016\/j.arcmed.2007.10.001_bib124","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1212\/WNL.62.1.66","article-title":"Rofecoxib: no effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study","volume":"62","author":"Reines","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.arcmed.2007.10.001_bib125","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/sj.npp.1300690","article-title":"A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment","volume":"30","author":"Thal","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.arcmed.2007.10.001_bib126","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/35102591","article-title":"A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity","volume":"414","author":"Weggen","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.arcmed.2007.10.001_bib127","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1471-4159.2004.02743.x","article-title":"Non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action","volume":"91","author":"Gasparini","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.arcmed.2007.10.001_bib128","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.neuint.2005.06.012","article-title":"Differential effects of COX inhibitors against \u03b2-amyloid-induced neurotoxicity in human neuroblastoma cells","volume":"47","author":"Ferrera","year":"2005","journal-title":"Neurochem Int"},{"key":"10.1016\/j.arcmed.2007.10.001_bib129","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.neuropharm.2005.07.004","article-title":"Non-steroidal anti-inflammatory drugs have anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro","volume":"49","author":"Hirohata","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.arcmed.2007.10.001_bib130","doi-asserted-by":"crossref","first-page":"30748","DOI":"10.1074\/jbc.M304824200","article-title":"Abeta42-lowering nonsteroidal anti-inflammatory drugs preserve intramembrane cleavage of the amyloid precursor protein (APP) and ErbB-4 receptor and signaling through the APP intracellular domain","volume":"278","author":"Weggen","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.arcmed.2007.10.001_bib131","doi-asserted-by":"crossref","first-page":"18664","DOI":"10.1074\/jbc.M301619200","article-title":"Sulindac sulfide is a noncompetitive secretase inhibitor that preferentially reduces Abeta42 generation","volume":"278","author":"Takahashi","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.arcmed.2007.10.001_bib132","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.2174\/138161206778793029","article-title":"Selective modulation of A\u03b2242 production in Alzheimer's disease: non-steroidal anti-inflammatory drugs and beyond","volume":"12","author":"Leuchtenberger","year":"2006","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.arcmed.2007.10.001_bib133","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/ncpneuro0039","article-title":"Can rofecoxib delay a diagnosis of Alzheimer's disease in patients with mild cognitive impairment?","volume":"1","author":"Aisen","year":"2005","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1016\/j.arcmed.2007.10.001_bib134","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neulet.2005.11.066","article-title":"Acetylsalicylic acid decreases tau phosphorylation at serine 422","volume":"396","author":"Tortosa","year":"2006","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.arcmed.2007.10.001_bib135","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1126\/science.1090154","article-title":"Nonsteroidal anti-inflammatory drugs can lower amyloidogenic Abeta42 by inhibiting Rho","volume":"302","author":"Zhou","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.arcmed.2007.10.001_bib136","doi-asserted-by":"crossref","first-page":"7504","DOI":"10.1523\/JNEUROSCI.23-20-07504.2003","article-title":"Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease","volume":"23","author":"Yan","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.arcmed.2007.10.001_bib137","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1523\/JNEUROSCI.22-06-02246.2002","article-title":"Microglial activation and beta-amyloid deposit reduction caused by a nitric oxide-releasing nonsteroidal anti-inflammatory drug in amyloid precursor protein plus presenilin-1 transgenic mice","volume":"22","author":"Jantzen","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.arcmed.2007.10.001_bib138","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/brain\/awh452","article-title":"Acute treatment with the PPAR\u03b3 agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice","volume":"128","author":"Heneka","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.arcmed.2007.10.001_bib139","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0002-9440(10)63269-5","article-title":"Modulation of nuclear factor-kB activity by indomethacin influences Ab\u00a0levels but not Ab precursor protein metabolism in a model of Alzheimer's disease","volume":"165","author":"Sung","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.arcmed.2007.10.001_bib140","unstructured":"Pratic\u00f2 D, Yao Y, Uryu K, Yang H, Trojanowsi JQ, Lee V. Opposite effects of indomethacin and nimesulide on and amyloid deposition in a transgenic mouse model of Alzheimer amyloidosis. 2003 Abstract Viewer\/Itinerary Planner, Program 20.4. Society for Neuroscience, Washington, DC. Online (2003)."},{"key":"10.1016\/j.arcmed.2007.10.001_bib141","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.brainresrev.2004.12.026","article-title":"Transgenic AD model mice, effects of potential anti-AD treatments on inflammation and pathology","volume":"48","author":"van Groen","year":"2005","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.arcmed.2007.10.001_bib142","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nm1235","article-title":"Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Ab42 production","volume":"11","author":"Kukar","year":"2005","journal-title":"Nature Med"},{"key":"10.1016\/j.arcmed.2007.10.001_bib143","unstructured":"Sagi SA, Eriksen JL, Beard J, Ozols V, Weggen S, Smith TE, et al. A\u03b242 lowering NSAIDs can be converted into A\u03b242 raising agents by simple structural modifications. 2003 Abstract Viewer\/Itinerary Planner, Program No. 76.14. Society for Neuroscience, Washington, DC. Online (2003)."},{"key":"10.1016\/j.arcmed.2007.10.001_bib144","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1096\/fj.04-3620rev","article-title":"Novel therapeutic opportunities for Alzheimer's disease: focus on nonsteroidal anti-inflammatory drugs","volume":"19","author":"Townsend","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.arcmed.2007.10.001_bib145","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3727\/000000002783992352","article-title":"Cyclooxygenase-2 promotes amyloid plaque deposition in a mouse model of\u00a0Alzheimer's disease neuropathology","volume":"10","author":"Xiang","year":"2002","journal-title":"Gene Expr"},{"key":"10.1016\/j.arcmed.2007.10.001_bib146","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.neuroscience.2006.05.001","article-title":"Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern","volume":"141","author":"Melnikova","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.arcmed.2007.10.001_bib147","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1126\/science.306.5702.1673","article-title":"Clinical trials. Nail-biting time for trials of COX-2 drugs","volume":"306","author":"Couzin","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.arcmed.2007.10.001_bib148","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.brainresrev.2004.12.029","article-title":"Activity of flurbiprofen and chemically related anti-inflammatory drugs in models of Alzheimer's disease","volume":"48","author":"Gasparini","year":"2005","journal-title":"Brain Res Brain Res Rev"},{"issue":"Suppl","key":"10.1016\/j.arcmed.2007.10.001_bib149","first-page":"10","article-title":"Disease modifying antirheumatic drugs: longterm safety issues","volume":"62","author":"Capell","year":"2001","journal-title":"J Rheumatol"},{"issue":"Suppl","key":"10.1016\/j.arcmed.2007.10.001_bib150","first-page":"121","article-title":"Nitric oxide-releasing NSAIDs: a novel class of GI-sparing anti-inflammatory drugs","volume":"46","author":"Wallace","year":"1995","journal-title":"Agents Actions"},{"key":"10.1016\/j.arcmed.2007.10.001_bib151","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.neuroscience.2006.10.020","article-title":"Amyloid-beta vaccination, but not nitro-nonsteroidal anti-inflammatory drug treatment, increases vascular amyloid and microhemorrhage while both reduce parenchymal amyloid","volume":"144","author":"Wilcock","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.arcmed.2007.10.001_bib152","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0006-291X(03)00731-9","article-title":"Molecular characterization of six alternatively spliced variants and a novel promoter in human peroxisome proliferator-activated receptor alpha","volume":"305","author":"Chew","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.arcmed.2007.10.001_bib153","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1046\/j.1471-4159.1998.70041366.x","article-title":"Distribution of mRNAs encoding the peroxisome proliferator-activated receptor alpha, beta, and gamma and the retinoid X receptor alpha, beta, and gamma in rat central nervous system","volume":"70","author":"Cullingford","year":"1998","journal-title":"J Neurochem"},{"key":"10.1016\/j.arcmed.2007.10.001_bib154","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1073\/pnas.0503839103","article-title":"Nonsteroidal anti-inflammatory drugs repress beta-secretase gene promoter activity by the activation of PPAR\u03b3","volume":"103","author":"Sastre","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.arcmed.2007.10.001_bib155","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/j.1365-2222.2006.02604.x","article-title":"Peroxisome proliferator-activated receptor-gamma agonists as potential anti-inflammatory agents in asthma and chronic obstructive pulmonary disease","volume":"36","author":"Spears","year":"2006","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.arcmed.2007.10.001_bib156","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0197-0186(01)00052-3","article-title":"Regulation of beta-amyloid stimulated proinflammatory responses by peroxisome proliferator-activated receptor alpha","volume":"39","author":"Combs","year":"2001","journal-title":"Neurochem Int"},{"key":"10.1016\/j.arcmed.2007.10.001_bib157","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0197-4580(01)00296-2","article-title":"Anti-inflammatory actions of peroxisome proliferator-activated receptor gamma agonists in Alzheimer's disease","volume":"22","author":"Landreth","year":"2001","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.arcmed.2007.10.001_bib158","doi-asserted-by":"crossref","first-page":"9796","DOI":"10.1523\/JNEUROSCI.23-30-09796.2003","article-title":"Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-gamma agonists modulate immunostimulated processing of amyloid precursor protein through regulation of beta-secretase","volume":"23","author":"Sastre","year":"2003","journal-title":"J Neurosci"},{"issue":"Suppl 1","key":"10.1016\/j.arcmed.2007.10.001_bib159","first-page":"S232","article-title":"The role of inflammation in CNS injury and disease","volume":"147","author":"Lucas","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.arcmed.2007.10.001_bib160","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1388-1981(02)00126-9","article-title":"Conjugated linoleic acid decreases production of proinflammatory products in macrophages: evidence for a PPAR gamma-dependent mechanism","volume":"1581","author":"Yu","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.arcmed.2007.10.001_bib161","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/00001756-200103260-00043","article-title":"15-deoxy-delta12,14-prostaglandin J2, a specific ligand for peroxisome proliferator-activated receptor-gamma, induces neuronal apoptosis","volume":"12","author":"Rohn","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.arcmed.2007.10.001_bib162","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/sj.tpj.6500383","article-title":"Genetic discoveries as the basis of personalized therapy: rosiglitazone treatment of Alzheimer's disease","volume":"6","author":"Hsueh","year":"2006","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.arcmed.2007.10.001_bib163","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/01.wad.0000213866.86934.7e","article-title":"Insulin resistance syndrome and Alzheimer disease: pathophysiologic mechanisms and therapeutic implications","volume":"20","author":"Craft","year":"2006","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1016\/j.arcmed.2007.10.001_bib164","first-page":"950","article-title":"Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study","volume":"13","author":"Watson","year":"2005","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.arcmed.2007.10.001_bib165","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1210\/jc.2006-2275","article-title":"Effects of the type 2 diabetes-associated pparg p12a polymorphism on progression to diabetes and response to troglitazone","volume":"92","author":"Florez","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2007.10.001_bib166","first-page":"73976","article-title":"Roles of cholesterol and lipids in the etiopathogenesis of Alzheimer's disease","volume":"2006","author":"Rojo","year":"2006","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.arcmed.2007.10.001_bib167","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0197-4580(97)00042-0","article-title":"Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's disease","volume":"18","author":"Webster","year":"1997","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.arcmed.2007.10.001_bib168","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/0006-8993(94)91640-3","article-title":"Ultrastructural localization of complement membrane attack complex (MAC)-like immunoreactivity in brains of patients with Alzheimer's disease","volume":"645","author":"Itagaki","year":"1994","journal-title":"Brain Res"},{"key":"10.1016\/j.arcmed.2007.10.001_bib169","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.neurobiolaging.2005.09.043","article-title":"Peripheral clearance of amyloid beta peptide by complement C3-dependent adherence to erythrocytes","volume":"27","author":"Rogers","year":"2006","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.arcmed.2007.10.001_bib170","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0304-3940(01)01842-0","article-title":"Complement activation by neurofibrillary tangles in Alzheimer's disease","volume":"305","author":"Shen","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.arcmed.2007.10.001_bib171","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neurobiolaging.2005.01.011","article-title":"Anomalously phosphorylated tau and Abeta fragments in the CSF correlates with cognitive impairment in MCI subjects","volume":"27","author":"Maccioni","year":"2006","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.arcmed.2007.10.001_bib172","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3233\/JAD-2005-8403","article-title":"Biomarkers for Alzheimer's disease\u2014clinical needs and application","volume":"8","author":"Galasko","year":"2005","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.arcmed.2007.10.001_bib173","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.exger.2004.07.007","article-title":"Increased plasma levels of soluble CD40, together with the decrease of TGF beta 1, as possible differential markers of Alzheimer disease","volume":"39","author":"Mocali","year":"2004","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.arcmed.2007.10.001_bib174","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0531-5565(02)00018-9","article-title":"Decrease of TGF-\u03b21 plasma levels and increase of nitric oxide synthase activity in leukocytes as potential biomarkers of Alzheimer's disease","volume":"37","author":"De Servi","year":"2002","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.arcmed.2007.10.001_bib175","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0022-3956(97)00023-X","article-title":"Circulating cytokines in Alzheimer's disease","volume":"31","author":"Singh","year":"1997","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.arcmed.2007.10.001_bib176","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0304-3940(94)90003-5","article-title":"Elevated interleukin-6 secretion levels by mononuclear cells of Alzheimer's patients","volume":"174","author":"Shalit","year":"1994","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.arcmed.2007.10.001_bib177","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0022-510X(95)00016-U","article-title":"IL-2 and IL-6 secretion in dementia: correlation with type and severity of disease","volume":"130","author":"Huberman","year":"1995","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.arcmed.2007.10.001_bib178","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0304-3940(97)00886-0","article-title":"Interleukin-6 (IL-6) and soluble forms of IL-6 receptors are not altered in cerebrospinal fluid of Alzheimer's disease patients","volume":"239","author":"Marz","year":"1997","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.arcmed.2007.10.001_bib179","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0006-8993(99)01146-4","article-title":"Discriminant power of combined cerebrospinal fluid tau protein and of the soluble interleukin-6 receptor complex in the diagnosis of Alzheimer's disease","volume":"823","author":"Hampel","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.arcmed.2007.10.001_bib180","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neulet.2005.03.051","article-title":"Cerebrospinal fluid tau, Abeta1-42 and inflammatory cytokines in patients with Alzheimer's disease and vascular dementia","volume":"383","author":"Jia","year":"2005","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.arcmed.2007.10.001_bib181","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1440-1789.2006.00701.x","article-title":"Interleukin-18 and transforming growth factor-beta 1 plasma levels in Alzheimer's disease and vascular dementia","volume":"26","author":"Motta","year":"2006","journal-title":"Neuropathology"},{"key":"10.1016\/j.arcmed.2007.10.001_bib182","doi-asserted-by":"crossref","first-page":"13203","DOI":"10.1073\/pnas.0605411103","article-title":"An internally controlled peripheral biomarker for Alzheimer's disease: Erk1 and Erk2 responses to the inflammatory signal bradykinin","volume":"103","author":"Khan","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.arcmed.2007.10.001_bib183","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0165-5728(94)90108-2","article-title":"Correlation of cytokine secretion by mononuclear cells of Alzheimer patients and their disease stage","volume":"52","author":"Huberman","year":"1994","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.arcmed.2007.10.001_bib184","first-page":"29","article-title":"Serum tumor necrosis factor (TNF) in Alzheimer's disease and multi-infarct dementia","volume":"16","author":"Cacabelos","year":"1994","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"10.1016\/j.arcmed.2007.10.001_bib185","first-page":"703","article-title":"Interleukin-1 in Alzheimer's disease and multi-infarct dementia: neuropsychological correlations","volume":"13","author":"Cacabelos","year":"1991","journal-title":"Methods Find Exp Clin Pharmacol"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440907003268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440907003268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:34:46Z","timestamp":1759260886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440907003268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":185,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0188440907003268"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2007.10.001","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroinflammation: Implications for the Pathogenesis and Molecular Diagnosis of Alzheimer's Disease","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2007.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 IMSS. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}